Briefly summarized, embodiments of the present invention are directed to a placement system for tracking, placing, and monitoring a catheter assembly or other medical device inserted into a body of a patient. The placement system utilizes optical fiber-based strain sensors to ascertain information regarding the catheter assembly during and/or after insertion into the patient's body.
In one embodiment, the placement system comprises a plurality of optical fiber-based strain sensors included with the medical device. A laser light source (or other suitable light source) is also included and configured to operably connect with the strain sensors and produce outgoing optical signals incident on the strain sensors. A photodetector is included and configured to operably connect with the strain sensors and receive return optical signals from the strain sensors. A processor is configured to process data from the return optical signals. The data relates to an aspect of the medical device. A user interface such as a display is configured to communicate information relating to the aspect of the medical device.
These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.
For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”
Embodiments of the present invention are generally directed to a placement system for tracking, placing, and monitoring a medical device inserted into a body of a patient. An example of such a medical device is a catheter assembly that is inserted into a vein or other vessel of the patient so as to infuse or aspirate fluids through one or more lumens defined by the catheter for the patient. The system utilizes optical fiber-based strain sensors in one embodiment to ascertain information regarding the catheter or other medical device during and/or after insertion into the patient's body.
In one embodiment, the strain sensors include fiber Bragg grating (“FBG”) sensors distributed along an optical fiber disposed in/on the catheter assembly (or other medical device). An outgoing optical signal produced by a swept laser is incident on each of the FBG sensors in the fiber, which each respond, producing a return optical signal. A processor of the placement system processes the return optical signal with predetermined algorithms to determine the strain and other data of each of the FBG sensors. The data is communicated to a user of the system and can provide information regarding the medical device, its position within the body, the 2-D and 3-D shape of the medical device along its length (e.g., bending, torsion), device orientation (including malposition or device kinking), body temperature, fluid level within the medical device, device pressure, stiffness, and operational load, etc. Such information is presented by the system to the user in real-time to assist in guiding and placing the medical device as desired within the patient. Additionally, measurements may be made by the system post-placement to ensure the medical device is functional and properly placed by interrogating the FBG sensors anew. Further details regarding these and other embodiments are given hereafter.
Note that, though the below discussion focuses on the placement of a catheter assembly into the body of the patient, the placement system described herein can be employed to place a variety of medical devices and components including other elongate and non-elongate medical devices in a variety of locations within the patient body. As such, the principles of the present disclosure should not be considered limiting to what is explicitly described herein. Examples of catheter assemblies and medical devices that may benefit from the present disclosure include a peripherally-inserted central catheter (“PICC”), central venous catheter (“CVC”), urinary catheter, midline catheter, peripheral catheter, an ECG lead, a needle, an NG tube, etc.
In light of the above, the optical fiber-based strain sensor system described above thus serves as one modality in the above-introduced medical device placement system for guiding and placing a medical device within the body of a patient. As such, this modality if also referred to herein as an “optical modality.” Note however that the placement system can also employ additional modalities for improving medical device placement accuracy, in addition to the optical modality introduced above and described in further detail below. In one embodiment an additional ultrasound (“US”) modality is also employed by the system to enable ultrasound-assisted guidance for introducing a catheter assembly (or other medical device) into the patient's vasculature. After such introduction to the vasculature, the optical modality to be described herein can thereafter be employed to guide the catheter assembly to a desired location within the vasculature. These modalities are described in further detail below. In one embodiment, the optical modality alone is employed by the system.
In yet another embodiment, additional modalities may be employed by the system to assist in guiding a catheter assembly (or other medical device) to a desired destination within the body of the patient. These include a tip location/navigation system (“TLS”) modality, wherein magnetically-based tracking of the catheter tip during its advancement through the tortuous vasculature path is employed to detect and facilitate correction of any tip malposition during such advancement; and an ECG modality, wherein ECG signal-based catheter tip guidance is employed to enable tracking and guidance of the catheter tip to a desired position with respect to a node of the patient's heart from which the ECG signals originate. Such ECG-based positional assistance is also referred to as “tip confirmation.” Further details regarding these modalities can be found in U.S. Pat. No. 8,781,555, filed Mar. 2, 2010, and titled System for Placement of a Catheter Including a Signal-Generating Stylet,” which is incorporated herein by reference in its entirety.
Use of the optical modality according to one embodiment enables the catheter placement system to facilitate catheter placement within the patient's vasculature with a relatively high level of accuracy, i.e., placement of the distal tip of the catheter in a predetermined and desired position. In one example implementation, use of the optical modality may result in correct tip placement being confirmed without the need for a confirmatory X-ray. This, in turn, reduces the patient's exposure to potentially harmful x-rays, the cost and time involved in transporting the patient to and from the x-ray department, costly and inconvenient catheter repositioning procedures, etc.
Reference is first made to
An example implementation of the console 20 is shown in
The system 10 further includes ports 52 for connection with the optical module 50 and optional components 54 including a printer, storage media, keyboard, etc. The ports in one embodiment are USB ports, though other port types or a combination of port types can be used for this and the other interfaces connections described herein. A power connection 56 is included with the console 20 to enable operable connection to an external power supply 58. An internal battery 60 can also be employed, either with or exclusive of an external power supply. Power management circuitry 59 is included with the digital controller/analog interface 24 of the console to regulate power use and distribution.
The display 30 in the present embodiment is integrated into the console 20 and is employed as a user interface to display information to the clinician during the catheter placement procedure. In another embodiment, the display may be separate from the console. As will be seen, the content depicted by the display 30 changes according to which mode the catheter placement system is in: optical, US, or other modality. In one embodiment, a console button interface 32 and buttons included on the probe 40 can be used to immediately call up a desired mode to the display 30 by the clinician to assist in the placement procedure. In one embodiment, information from multiple modes, such as optical and US, may be displayed simultaneously. Thus, the single display 30 of the system console 20 can be employed for ultrasound guidance in accessing a patient's vasculature and optical modality-based guidance during catheter advancement through the vasculature. In one embodiment, the display 30 is an LCD device.
The probe 40 is employed in connection with the first modality mentioned above, i.e., ultrasound (“US”)-based visualization of a vessel, such as a vein, in preparation for insertion of the catheter 72 into the vasculature. Such visualization gives real time ultrasound guidance for introducing the catheter into the vasculature of the patient and assists in reducing complications typically associated with such introduction, including inadvertent arterial puncture, hematoma, pneumothorax, etc.
The handheld probe 40 includes a head that houses a piezoelectric array for producing ultrasonic pulses and for receiving echoes thereof after reflection by the patient's body when the head is placed against the patient's skin proximate the prospective insertion site 73 (
As such, in one embodiment a clinician employs the first (US) modality to determine a suitable insertion site and establish vascular access, such as with a needle or introducer, then with the catheter. The clinician can then seamlessly switch, via button pushes on the probe button pad 82, to the optical modality without having to reach out of the sterile field. Again, the optical modality can be used to assist in advancement of the catheter 72 through the vasculature toward an intended destination.
The handheld ultrasound probe 40 is employed to enable US visualization of the peripheral vasculature of a patient in preparation for transcutaneous introduction of the catheter. In the present example embodiment, however, the probe is also employed to control functionality of other modalities of the system 10, including the optical modality, when navigating the catheter toward its desired destination within the vasculature as described below. Again, as the probe 40 is used within the sterile field of the patient, this feature enables functionality of any one of the modalities to be controlled entirely from within the sterile field. Thus the probe 40 is a multi-purpose device, enabling convenient control of both US and other modality functionality of the system 10 from the sterile field. Note that additional or fewer components can be included with the system 10 than what is shown and described herein.
As mentioned, the system 10 includes the optical module 50, which is shown in further detail ion
Along with
In greater detail, the fiber-bearing portion 138 includes, as seen in
As shown in
Note further that, though described herein as a stylet, in other embodiments a guidewire or other catheter guiding apparatus could include the components and functionality described herein. Indeed, it should appreciated that “stylet” as used herein can include any one of a variety of devices configured for removable placement within a lumen of the catheter (or other portion of a medical device) to assist in placing a distal end of the catheter in a desired location within the patient's vasculature. Also, note that other connection schemes between the stylet 130 and the system 10/console 20 can also be used without limitation.
Note that a sterile drape is often positioned over the patient 70 during the catheter insertion procedure in order to define the majority of a sterile field: areas above the drape are sterile, while areas below (excluding the insertion site and immediately surrounding region) are non-sterile. For instance, areas and components above the drape and proximate to the insertion site 73 (including the catheter 72, the stylet 130, and tether 134) are included in the sterile field, while areas and components below the drape, including the patient's chest and regions immediately surrounding the patient 70 are considered a non-sterile field. In cases where the tether 134 of the stylet 130 needs to penetrate the drape in order to pass between the sterile and non-sterile fields, suitable connection nodes can be included with the stylet in order to pierce the drape while not compromising the sterile field. U.S. Pat. No. 8,781,555, incorporated by reference above, includes various examples of drape-piercing embodiments that can be employed to enable the stylet to acceptably pass through the drape while still enabling outgoing and return optical signals, as well as other signals, to pass between the optical fiber 140 and the console 20.
The strain sensors 204 in one embodiment can be included with an optical fiber that is in turn included in a fiber-bearing of a stylet, such as the stylet 130 described above in connection with
In the present embodiment, the strain sensors 204 are configured as fiber Bragg grating (“FBG”) sensors. The FBG sensors 34 are each configured to detect strain of the optical fiber at each sensor location, thus enabling the shape and movement of the optical fiber, and thus the catheter tube 150 with which it is included, to be detected and determined as the catheter is inserted into the body of the patient 70, as explained immediately below.
In greater detail, once the catheter 72 has been introduced into the patient vasculature via the insertion site 73 (
In one embodiment and in light of the above, therefore, a method for placing a catheter assembly (or other medical device) into a body of a patient includes stages: propagating an outgoing optical signal to a plurality of optical fiber-based strain sensors included with the catheter assembly; receiving a return optical signal from the strain sensors; and processing the return optical signal received from the strain sensors to derive data relating to the medical device. These stages are successively repeated while inserting the catheter assembly into the body of the patient so as to guide the catheter assembly to its intended destination.
This above-described process results in specified strain data to be correlated along the sensor-equipped length of the optical fiber 140. In turn, given the disposal of the optical fiber 140 within the lumen 216 of the catheter tube 150, the strain data enables information regarding the two- and three-dimensional shape of the catheter tube 150 within the patient of the patient 70 to be ascertained, given that the detected strain-related displacement, bending, pressure, and torsion/twisting of the optical fiber 140 correlates to the catheter tube itself in which the optical fiber is disposed. This and other informational aspects relating to the data collected from the sensors 204 can be communicated to the user of the system 1, via the display 30 and/or other suitable user interface mode, to assist the user in knowing the location, orientation and shape of the catheter 72 within the patient vasculature, thus enabling the user to advance the catheter distally and position the distal tip 76B of the catheter in a desired location therein, in part by the fact that the distal end of the sensor-equipped optical fiber 140 is substantially co-terminal with the distal tip of the catheter within the vasculature, in the present embodiment. The process of sending and receiving outgoing and return optical signals, respectively, occurs iteratively during system operation such that position, orientation, and shape information relating to the catheter 72 is continuously received by the user via the system 10 during the catheter placement procedure.
Once it has been positioned as desired using the system 10 as just described, the catheter 72 may be secured in place and the stylet 130 removed from the catheter lumen. It is noted here that the stylet may include one of a variety of configurations in addition to what is explicitly described herein. In one embodiment, the stylet can attach directly or indirectly to the console. In another embodiment, the optical fiber of the stylet can be integrated into the catheter structure itself, thus eliminating the need for the stylet in bearing the optical fiber and included strain sensors.
Note that in one embodiment the console 20 includes the electronic components, such as the processor 22 (
In the present embodiment, the position, orientation, shape, and other information regarding the catheter 72, as provided by the optical fiber-based sensors 204 and as described above is communicated to the user of the system 10 to assist with placing the distal tip 76B (or other portion of the catheter) at a desired location within the patient vasculature/body, such as the lower ⅓rd of the superior vena cava. In the present embodiment, such information is depicted on the display 30, included on the console 20 as part of the system 10, though it can be configured in other ways as well, including as a separate component in one embodiment. As has been described further above, the functionality of the display 30 can be controlled by control buttons 84 included on the handheld probe 40 (
During initial startup and preparation for insertion of the catheter 72 into the patient vasculature, the display screenshot may indicate “no signal,” as seen in
In
In one embodiment it is appreciated that the mapping of the catheter as an image on the body image 320 to indicate the actual location of the catheter 72 within the actual body of the patient 70 is enabled by knowledge of the insertion site of the catheter (i.e., a reference location) —here represented by the insertion site 332 of
It should be appreciated that the use of optical fiber-based sensors can be employed to confirm that a previously inserted catheter assembly (or other medical device) is still positioned as desired within the body of the patient. In one embodiment, this is achieved by feeding a stylet including an optical fiber-based series of strain sensors distally within a lumen of the catheter until reaching the distal tip of the catheter. Strain and other measurements may then be performed by the sensors disposed within the catheter lumen, thus enabling the system with which the sensors are operably connected to determine the shape, orientation, and position of the catheter tube within the vasculature of the patient, including the termination point of the catheter distal tip. This enables a clinician to ensure the catheter is still positioned at the desired location.
In addition to strain, stress, and torsion measurements that enable the two- and three-dimensional shape, position, and orientation of the catheter or other medical device to be determined while in the patient body, the optical modality described herein can detect and communicate other information to the clinician via the system 10 using the data provided by the sensor interrogation by the outgoing optical signals and the resultant return optical signals. Such information includes temperature, pressure, stiffness, strength, operational load on the catheter tube, liquid level within the lumen 14, blood oxygen level, magnetic field presence, etc. Further, it is appreciated that, in light of the above disclosure, other conditions relating to the catheter may be detected, including malposition/misdirection during catheter advancement including contralateral and U placement, arterial vs. venous placement, venous pressure and core body temperature, confirmation of the catheter staying within the true lumen of the vein or other vessel in the case of navigation through chronic total occlusion or other vessel blockage scenarios, etc.
Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application claims the benefit of U.S. Provisional Application No. 62/483,195, filed Apr. 7, 2017, and titled “Optical Fiber-Based Medical Device Tracking and Monitoring System,” which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4813429 | Eshel et al. | Mar 1989 | A |
5099845 | Besz et al. | Mar 1992 | A |
5163935 | Black et al. | Nov 1992 | A |
5207672 | Roth et al. | May 1993 | A |
5211165 | Dumoulin et al. | May 1993 | A |
5275151 | Shockey et al. | Jan 1994 | A |
5280786 | Włodarczyk et al. | Jan 1994 | A |
5423321 | Fontenot | Jun 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5517997 | Fontenot | May 1996 | A |
5622170 | Schulz | Apr 1997 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5872879 | Hamm | Feb 1999 | A |
5873842 | Brennen et al. | Feb 1999 | A |
5879306 | Fontenot et al. | Mar 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
6069698 | Ozawa et al. | May 2000 | A |
6081741 | Hollis | Jun 2000 | A |
6178346 | Amundson et al. | Jan 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6319227 | Mansouri-Ruiz | Nov 2001 | B1 |
6343227 | Crowley | Jan 2002 | B1 |
6398721 | Nakamura et al. | Jun 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6593884 | Gilboa et al. | Jul 2003 | B1 |
6597941 | Fontenot et al. | Jul 2003 | B2 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6685666 | Fontenot | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6690966 | Rava et al. | Feb 2004 | B1 |
6701181 | Tang et al. | Mar 2004 | B2 |
6711426 | Benaron et al. | Mar 2004 | B2 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6892090 | Verard et al. | May 2005 | B2 |
6895267 | Panescu et al. | May 2005 | B2 |
7132645 | Korn | Nov 2006 | B2 |
7273056 | Wilson et al. | Sep 2007 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7366562 | Dukesherer et al. | Apr 2008 | B2 |
7366563 | Kleen et al. | Apr 2008 | B2 |
7396354 | Rychnovsky et al. | Jul 2008 | B2 |
7406346 | Kleen et al. | Jul 2008 | B2 |
7515265 | Alfano et al. | Apr 2009 | B2 |
7532920 | Ainsworth et al. | May 2009 | B1 |
7587236 | Demos et al. | Sep 2009 | B2 |
7603166 | Casscells, III et al. | Oct 2009 | B2 |
7729735 | Burchman | Jun 2010 | B1 |
7757695 | Wilson et al. | Jul 2010 | B2 |
7758499 | Adler | Jul 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7992573 | Wilson et al. | Aug 2011 | B2 |
8032200 | Tearney et al. | Oct 2011 | B2 |
8054469 | Nakabayashi et al. | Nov 2011 | B2 |
8060187 | Marshik-Geurts et al. | Nov 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8078261 | Imam | Dec 2011 | B2 |
8187189 | Jung et al. | May 2012 | B2 |
8267932 | Baxter et al. | Sep 2012 | B2 |
8369932 | Cinbis et al. | Feb 2013 | B2 |
8388541 | Messerly et al. | Mar 2013 | B2 |
8571640 | Holman | Oct 2013 | B2 |
8597315 | Snow et al. | Dec 2013 | B2 |
8700358 | Parker, Jr. | Apr 2014 | B1 |
8781555 | Burnside | Jul 2014 | B2 |
8798721 | Dib | Aug 2014 | B2 |
8968331 | Sochor | Mar 2015 | B1 |
8979871 | Tyc et al. | Mar 2015 | B2 |
9060687 | Yamanaka et al. | Jun 2015 | B2 |
9206309 | Appleby et al. | Dec 2015 | B2 |
9360630 | Jenner et al. | Jun 2016 | B2 |
9504392 | Caron et al. | Nov 2016 | B2 |
9560954 | Jacobs et al. | Feb 2017 | B2 |
9622706 | Dick et al. | Apr 2017 | B2 |
9678275 | Griffin | Jun 2017 | B1 |
10231753 | Burnside et al. | Mar 2019 | B2 |
10258240 | Eberle et al. | Apr 2019 | B1 |
10327830 | Grant et al. | Jun 2019 | B2 |
10349890 | Misener et al. | Jul 2019 | B2 |
10492876 | Anastassiou et al. | Dec 2019 | B2 |
10568586 | Begin et al. | Feb 2020 | B2 |
10631718 | Petroff et al. | Apr 2020 | B2 |
10992078 | Thompson et al. | Apr 2021 | B2 |
11123047 | Jaffer et al. | Sep 2021 | B2 |
11525670 | Messerly et al. | Dec 2022 | B2 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20040242995 | Maschke | Dec 2004 | A1 |
20050033264 | Redinger | Feb 2005 | A1 |
20050261598 | Banet et al. | Nov 2005 | A1 |
20050278010 | Richardson | Dec 2005 | A1 |
20060013523 | Childlers et al. | Jan 2006 | A1 |
20060015136 | Besselink | Jan 2006 | A1 |
20060036164 | Wilson | Feb 2006 | A1 |
20060189959 | Schneiter | Aug 2006 | A1 |
20060200049 | Leo et al. | Sep 2006 | A1 |
20060241395 | Kruger et al. | Oct 2006 | A1 |
20060241492 | Boese et al. | Oct 2006 | A1 |
20070156019 | Larkin | Jul 2007 | A1 |
20070201793 | Askins et al. | Aug 2007 | A1 |
20070287886 | Saadat | Dec 2007 | A1 |
20070299425 | Waner et al. | Dec 2007 | A1 |
20080039715 | Wilson et al. | Feb 2008 | A1 |
20080082004 | Banet et al. | Apr 2008 | A1 |
20080172119 | Yamasaki et al. | Jul 2008 | A1 |
20080183128 | Morriss | Jul 2008 | A1 |
20090054908 | Zand et al. | Feb 2009 | A1 |
20090062634 | Say et al. | Mar 2009 | A1 |
20090118612 | Grunwald et al. | May 2009 | A1 |
20090137952 | Ramamurthy et al. | May 2009 | A1 |
20090234328 | Cox | Sep 2009 | A1 |
20090304582 | Rousso et al. | Dec 2009 | A1 |
20090314925 | Van Vorhis et al. | Dec 2009 | A1 |
20100016729 | Futrell | Jan 2010 | A1 |
20100030063 | Lee et al. | Feb 2010 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
20100114115 | Schlesinger et al. | May 2010 | A1 |
20100286531 | Ryan et al. | Nov 2010 | A1 |
20100312095 | Jenkins et al. | Dec 2010 | A1 |
20110144481 | Feer et al. | Jun 2011 | A1 |
20110166442 | Sarvazyan | Jul 2011 | A1 |
20110172680 | Younge et al. | Jul 2011 | A1 |
20110237958 | Onimura | Sep 2011 | A1 |
20110245662 | Eggers et al. | Oct 2011 | A1 |
20110295108 | Cox et al. | Dec 2011 | A1 |
20110313280 | Govari et al. | Dec 2011 | A1 |
20120046562 | Powers | Feb 2012 | A1 |
20120065481 | Hunter et al. | Mar 2012 | A1 |
20120101413 | Beetel et al. | Apr 2012 | A1 |
20120136242 | Qi et al. | May 2012 | A1 |
20120143029 | Silverstein et al. | Jun 2012 | A1 |
20120184827 | Shwartz et al. | Jul 2012 | A1 |
20120184955 | Pivotto et al. | Jul 2012 | A1 |
20120289783 | Duindam et al. | Nov 2012 | A1 |
20120321243 | Younge et al. | Dec 2012 | A1 |
20130072943 | Parmar | Mar 2013 | A1 |
20130096482 | Bertrand et al. | Apr 2013 | A1 |
20130104884 | Vazales et al. | May 2013 | A1 |
20130188855 | Desjardins et al. | Jul 2013 | A1 |
20130204124 | Duindam et al. | Aug 2013 | A1 |
20130211246 | Parasher | Aug 2013 | A1 |
20130296693 | Wenzel et al. | Nov 2013 | A1 |
20130310668 | Young | Nov 2013 | A1 |
20130317372 | Eberle et al. | Nov 2013 | A1 |
20130324840 | Zhongping et al. | Dec 2013 | A1 |
20140121468 | Eichenholz | May 2014 | A1 |
20140221829 | Maitland et al. | Aug 2014 | A1 |
20140275997 | Chopra et al. | Sep 2014 | A1 |
20150029511 | T Hooft et al. | Jan 2015 | A1 |
20150031987 | Pameijer et al. | Jan 2015 | A1 |
20150080688 | Cinbis et al. | Mar 2015 | A1 |
20150099979 | Caves et al. | Apr 2015 | A1 |
20150119700 | Liang et al. | Apr 2015 | A1 |
20150141854 | Eberle et al. | May 2015 | A1 |
20150164571 | Saadat | Jun 2015 | A1 |
20150190221 | Schaefer et al. | Jul 2015 | A1 |
20150209113 | Burkholz et al. | Jul 2015 | A1 |
20150209117 | Flexman et al. | Jul 2015 | A1 |
20150254526 | Denissen | Sep 2015 | A1 |
20150320977 | Vitullo | Nov 2015 | A1 |
20160018602 | Govari et al. | Jan 2016 | A1 |
20160067449 | Misener et al. | Mar 2016 | A1 |
20160102969 | Verstege et al. | Apr 2016 | A1 |
20160166326 | Bakker | Jun 2016 | A1 |
20160166341 | Iordachita et al. | Jun 2016 | A1 |
20160184020 | Kowalewski et al. | Jun 2016 | A1 |
20160354038 | Demirtas et al. | Dec 2016 | A1 |
20170020394 | Harrington | Jan 2017 | A1 |
20170079681 | Burnside et al. | Mar 2017 | A1 |
20170082806 | Van Der Mark et al. | Mar 2017 | A1 |
20170173349 | Pfleiderer et al. | Jun 2017 | A1 |
20170196479 | Liu et al. | Jul 2017 | A1 |
20170201036 | Cohen et al. | Jul 2017 | A1 |
20170215973 | Flexman et al. | Aug 2017 | A1 |
20170231699 | Flexman et al. | Aug 2017 | A1 |
20170273542 | Au | Sep 2017 | A1 |
20170273565 | Ma | Sep 2017 | A1 |
20170273628 | Ofek et al. | Sep 2017 | A1 |
20170290563 | Cole et al. | Oct 2017 | A1 |
20180095231 | Lowell et al. | Apr 2018 | A1 |
20180113038 | Janabi-Sharifi | Apr 2018 | A1 |
20180140170 | Van Putten et al. | May 2018 | A1 |
20180239124 | Naruse et al. | Aug 2018 | A1 |
20180240237 | Donhowe et al. | Aug 2018 | A1 |
20180250088 | Brennan et al. | Sep 2018 | A1 |
20180264227 | Flexman et al. | Sep 2018 | A1 |
20180289390 | Amorizzo et al. | Oct 2018 | A1 |
20180289927 | Messerly | Oct 2018 | A1 |
20180339134 | Leo | Nov 2018 | A1 |
20180360545 | Cole et al. | Dec 2018 | A1 |
20190059743 | Ramachandran | Feb 2019 | A1 |
20190110844 | Misener et al. | Apr 2019 | A1 |
20190237902 | Thompson et al. | Aug 2019 | A1 |
20190307331 | Saadat et al. | Oct 2019 | A1 |
20190321110 | Grunwald et al. | Oct 2019 | A1 |
20190343424 | Blumenkranz et al. | Nov 2019 | A1 |
20190357875 | Qi et al. | Nov 2019 | A1 |
20190374130 | Bydlon et al. | Dec 2019 | A1 |
20200030575 | Bogusky et al. | Jan 2020 | A1 |
20200046434 | Graetzel et al. | Feb 2020 | A1 |
20200054399 | Duindam et al. | Feb 2020 | A1 |
20200188036 | Ding et al. | Jun 2020 | A1 |
20200315770 | Dupont et al. | Oct 2020 | A1 |
20210015470 | Prisco et al. | Jan 2021 | A1 |
20210023341 | Decheek et al. | Jan 2021 | A1 |
20210045814 | Thompson et al. | Feb 2021 | A1 |
20210068911 | Walker et al. | Mar 2021 | A1 |
20210298680 | Sowards et al. | Mar 2021 | A1 |
20210244311 | Zhao et al. | Aug 2021 | A1 |
20210268229 | Sowards et al. | Sep 2021 | A1 |
20210271035 | Sowards et al. | Sep 2021 | A1 |
20210275257 | Prior et al. | Sep 2021 | A1 |
20210330399 | Netravali et al. | Oct 2021 | A1 |
20210401456 | Cox et al. | Dec 2021 | A1 |
20210401509 | Misener et al. | Dec 2021 | A1 |
20210402144 | Messerly | Dec 2021 | A1 |
20220011192 | Misener et al. | Jan 2022 | A1 |
20220034733 | Misener et al. | Feb 2022 | A1 |
20220096796 | McLaughlin et al. | Mar 2022 | A1 |
20220110695 | Sowards et al. | Apr 2022 | A1 |
20220152349 | Sowards et al. | May 2022 | A1 |
20220160209 | Sowards et al. | May 2022 | A1 |
20220172354 | Misener et al. | Jun 2022 | A1 |
20220211442 | McLaughlin et al. | Jul 2022 | A1 |
20220233246 | Misener et al. | Jul 2022 | A1 |
20220369934 | Sowards et al. | Nov 2022 | A1 |
20230081198 | Sowards et al. | Mar 2023 | A1 |
20230097431 | Sowards et al. | Mar 2023 | A1 |
20230101030 | Misener et al. | Mar 2023 | A1 |
20230108604 | Messerly et al. | Apr 2023 | A1 |
20230126813 | Sowards et al. | Apr 2023 | A1 |
20230243715 | Misener et al. | Aug 2023 | A1 |
20230248444 | Misener et al. | Aug 2023 | A1 |
20230251150 | Misener et al. | Aug 2023 | A1 |
20230337985 | Sowards et al. | Oct 2023 | A1 |
20230414112 | Misener et al. | Dec 2023 | A1 |
20240000515 | Misener et al. | Jan 2024 | A1 |
20240050708 | Misener | Feb 2024 | A1 |
20240099659 | Sowards et al. | Mar 2024 | A1 |
20240108856 | Messerly | Apr 2024 | A1 |
20240216077 | Thompson et al. | Jul 2024 | A1 |
Number | Date | Country |
---|---|---|
101132730 | Feb 2008 | CN |
111265309 | Jun 2020 | CN |
113080937 | Jul 2021 | CN |
102016109601 | Nov 2017 | DE |
2240111 | Oct 2010 | EP |
2907445 | Aug 2015 | EP |
3545849 | Oct 2019 | EP |
3705020 | Sep 2020 | EP |
7366562 | Oct 2023 | JP |
20190098512 | Aug 2019 | KR |
9964099 | Dec 1999 | WO |
1999064099 | Dec 1999 | WO |
2006122001 | Nov 2006 | WO |
2009155325 | Dec 2009 | WO |
2011121516 | Oct 2011 | WO |
WO-2011141830 | Nov 2011 | WO |
2011150376 | Dec 2011 | WO |
2012064769 | May 2012 | WO |
2015044930 | Apr 2015 | WO |
2015074045 | May 2015 | WO |
2016038492 | Mar 2016 | WO |
2016061431 | Apr 2016 | WO |
2016051302 | Apr 2016 | WO |
2016149819 | Sep 2016 | WO |
2019037071 | Feb 2019 | WO |
2019046769 | Mar 2019 | WO |
2019070423 | Apr 2019 | WO |
2019230713 | Dec 2019 | WO |
2020182997 | Sep 2020 | WO |
2021030092 | Feb 2021 | WO |
2021108688 | Jun 2021 | WO |
2021108697 | Jun 2021 | WO |
2021138096 | Jul 2021 | WO |
2021216089 | Oct 2021 | WO |
2022031613 | Feb 2022 | WO |
2022081723 | Apr 2022 | WO |
2022150411 | Jul 2022 | WO |
2022164902 | Aug 2022 | WO |
2022245987 | Nov 2022 | WO |
2023043954 | Mar 2023 | WO |
2023049443 | Mar 2023 | WO |
2023055810 | Apr 2023 | WO |
2023076143 | May 2023 | WO |
2023211752 | Nov 2023 | WO |
2024006384 | Jan 2024 | WO |
2024006441 | Jan 2024 | WO |
2024064334 | Mar 2024 | WO |
Entry |
---|
PCT/US2018/026493 filed Apr. 6, 2018 International Search Report and Written Opinion dated Jun. 22, 2018. |
PCT/US2020/044801 filed Aug. 3, 2020 International Search Report and Written Opinion dated Oct. 26, 2020. |
PCT/US2021/019713 filed Feb. 25, 2021 International Search Report and Written Opinion dated Jul. 6, 2021. |
PCT/US2021/020079 filed Feb. 26, 2021 International Search Report and Written Opinion dated Jun. 4, 2021. |
PCT/US2020/062396 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 2, 2021. |
PCT/US2020/062407 filed Nov. 25, 2020 International Search Report and Written Opinion dated Mar. 11, 2021. |
PCT/US2021/020732 filed Mar. 3, 2021 International Search Report and Written Opinion dated Jul. 5, 2021. |
PCT/US2021/038899 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 6, 2021. |
PCT/US2021/038954 filed Jun. 24, 2021 International Search Report and Written Opinion dated Oct. 28, 2021. |
PCT/US2021/041128 filed Jul. 9, 2021 International Search Report and Written Opinion dated Oct. 25, 2021. |
PCT/US2021/044216 filed Aug. 2, 2021 International Search Report and Written Opinion dated Nov. 18, 2021. |
U.S. Appl. No. 17/185,777, filed Feb. 25, 2021 Non-Final Office Action dated Feb. 9, 2022. |
PCT/US2021/054802 filed Oct. 13, 2021 International Search Report and Written Opinion dated Feb. 2, 2022. |
PCT/US2021/060849 filed Nov. 24, 2021 International Search Report and Written Opinion dated Mar. 9, 2022. |
PCT/US2022/011347 filed Jan. 5, 2022 International Search Report and Written Opinion dated May 3, 2022. |
PCT/US2022/013897 filed Jan. 26, 2022 International Search Report and Written Opinion dated May 11, 2022. |
U.S. Appl. No. 17/105,259, filed Nov. 25, 2020, Notice of Allowance dated Jul. 20, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Non-Final Office Action dated Jul. 12, 2022. |
PCT/US2023/033471 filed Sep. 22, 2023 International Search Report and Written Opinion dated Dec. 21, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Notice of Allowance dated Nov. 21, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Advisory Action dated Dec. 7, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Non-Final Office Action dated Jan. 19, 2024. |
U.S. Appl. No. 18/079,653, filed Dec. 12, 2022 Non-Final Office Action dated Feb. 6, 2024. |
U.S. Appl. No. 18/135,337, filed Apr. 17, 2023 Non-Final Office Action dated Dec. 22, 2023. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Non-Final Office Action dated Jan. 8, 2024. |
PCT/US2022/029894 filed May 18, 2022, International Search Report and Written Opinion dated Sep. 1, 2022. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Non-Final Office Action dated Aug. 11, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Non-Final Office Action dated Sep. 12, 2022. |
EP 20853352.1 filed Mar. 7, 2022 Extended European Search Report dated Jul. 27, 2023. |
PCT/US2023/019239 filed Apr. 20, 2023 International Search Report and Written Opinion dated Jul. 20, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Non-Final Office Action dated Jun. 22, 2023. |
U.S. Appl. No. 17/105,310, filed Nov. 25, 2020 Notice of Allowance dated Aug. 2, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Non Final Office Action dated May 30, 2023. |
U.S. Appl. No. 17/484,960, filed Sep. 24, 2021 Notice of Allowance dated Apr. 12, 2024. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Final Office Action dated Apr. 23, 2024. |
U.S. Appl. No. 17/747,903, filed May 18, 2022 Restriction Requirement dated May 28, 2024. |
U.S. Appl. No. 18/132,623, filed Apr. 10, 2023, Non-Final Office Action dated May 3, 2024. |
U.S. Appl. No. 18/135,337, filed Apr. 17, 2023 Notice of Allowance dated Mar. 8, 2024. |
Fiber Optic RealShape (FORS) technology—research. Philips. (Oct. 18, 2018). Retrieved Feb. 28, 2023, from https:// www.philips.com/a-w/research/research-programs/fors.html (Year: 2018). |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Restriction Requirement dated Mar. 13, 2023. |
U.S. Appl. No. 17/105,310, filed Nov. 25, 2020 Non-Final Office Action dated Feb. 22, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Restriction Requirement dated Mar. 7, 2023. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Corrected Notice of Allowability dated Feb. 23, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Non-Final Office Action dated Mar. 15, 2023. |
Jackle Sonja et al. “Three-dimensional guidance including shape sensing of a stentgraft system for endovascular aneurysm repair.” International Journal of Computer Assisted Radiology and Surgery, Springer DE. vol. 15, No. 6, May 7, 2020. |
PCT/US2022/043706 filed Sep. 16, 2022 International Search Report and Written Opinion dated Nov. 24, 2022. |
PCT/US2022/044696 filed Sep. 26, 2022 International Search Report and Written Opinion dated Jan. 23, 2023. |
PCT/US2022/045051 filed Sep. 28, 2022 International Search Report and Written Opinion dated Jan. 2, 2023. |
U.S. Appl. No. 17/357,561, filed Jun. 24, 2021 Notice of Allowance dated Dec. 9, 2022. |
U.S. Appl. No. 17/371,993, filed Jul. 9, 2021 Notice of Allowance dated Nov. 3, 2022. |
U.S. Appl. No. 17/392,002, filed Aug. 2, 2021, Notice of Allowance dated Jan. 19, 2023. |
Dziuda L et al: “Monitoring Respiration and Cardiac Activity Using Fiber Bragg Grating-Based Sensor”, IEEE Transactions on Biomedical Engineering vol. 59, No. 7, Jul. 2012 pp. 1934-1942. |
Dziuda L et al: “Fiber-optic sensor for monitoring respiration and cardiac activity”, 2011 IEEE Sensors Proceedings : Limerick, Ireland, Oct. 2011 pp. 413-416. |
EP 20893677.3 filed Jun. 22, 2022 Extended European Search Report dated Oct. 13, 2023. |
EP 20894633.5 filed Jun. 22, 2022 Extended European Search Report dated Oct. 16, 2023. |
PCT/US2023/026487 filed Jun. 28, 2023 International Search Report and Written Opinion dated Sep. 6, 2023. |
PCT/US2023/026581 filed Jun. 29, 2023 International Search Report and Written Opinion dated Oct. 27, 2023. |
U.S. Appl. No. 16/984,104, filed Aug. 3, 2020 Final Office Action dated Sep. 21, 2023. |
U.S. Appl. No. 17/357,186, filed Jun. 24, 2021 Notice of Allowance dated Aug. 23, 2023. |
U.S. Appl. No. 17/484,960, filed Sep. 24, 2021 Non-Final Office Action dated Oct. 5, 2023. |
U.S. Appl. No. 17/500,678, filed Oct. 13, 2021 Final Office Action dated Sep. 21, 2023. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Advisory Action dated Jul. 12, 2024. |
U.S. Appl. No. 17/747,903, filed May 18, 2022 Non-Final Office Action dated Aug. 15, 2024. |
U.S. Appl. No. 17/955,019, filed Sep. 28, 2022 Restriction Requirement dated Jun. 6, 2024. |
U.S. Appl. No. 18/079,653, filed Dec. 12, 2022 Notice of Allowance dated Jun. 4, 2024. |
U.S. Appl. No. 18/132,231, filed Apr. 7, 2023 Non-Final Office Action dated Jul. 12, 2024. |
U.S. App. No. 18/538,111 filed Dec. 13, 2023 Non-Final Office Action dated Aug. 9, 2024. |
U.S. Appl. No. 17/569,350, filed Jan. 5, 2022 Non-Final Office Action dated Aug. 12, 2024. |
U.S. Appl. No. 17/971,873, filed Oct. 24, 2022 Non-Final Office Action dated Jun. 6, 2024. |
Number | Date | Country | |
---|---|---|---|
20180289927 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
62483195 | Apr 2017 | US |